CytoMed Therapeutics Ltd

GDTC

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001873093

SEC filings (opens in a new tab)

In the last 90 days, CytoMed Therapeutics Ltd insiders filed 1 open-market purchase and 0 sales; 3 institutions reported holding it in 13F filings for Q2 2026, worth $12.2K in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding CytoMed Therapeutics Ltd changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of GDTC: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Q4 2023	Change
Holders	2	2	0
Shares	5.88K	4.38K	−1.50K (−25.5%)
Value	$20.7K	$21.5K	+$802 (+3.9%)

New holders (1)

Institutions that held CytoMed Therapeutics Ltd at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to GDTC in Q4 2023
Institution	Shares	Value	% of portfolio
Tower Research Capital LLC (TRC)	882	$4.32K	0.00%

Sold out (1)

Institutions that held CytoMed Therapeutics Ltd at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of GDTC in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Clear Street Markets LLC	5,407	$19.0K